lipoxin a4 and paraquat

lipoxin a4 has been researched along with paraquat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hong, Y; Li, Y; Ma, Z; Wang, N; Wang, Y; Yuan, Y; Zhao, M; Zhong, Z	1

Other Studies

1 other study(ies) available for lipoxin a4 and paraquat

Article	Year
Lipoxin A4 protects against paraquat‑induced acute lung injury by inhibiting the TLR4/MyD88‑mediated activation of the NF‑κB and PI3K/AKT pathways. International journal of molecular medicine, 2021, Volume: 47, Issue:5 Topics: Acute Lung Injury; Animals; Cytokines; Lipoxins; Male; Malondialdehyde; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Paraquat; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Pulmonary Edema; Rats, Sprague-Dawley; RAW 264.7 Cells; Superoxide Dismutase; Toll-Like Receptor 4	2021

Article

Year

Lipoxin A4 protects against paraquat‑induced acute lung injury by inhibiting the TLR4/MyD88‑mediated activation of the NF‑κB and PI3K/AKT pathways.

International journal of molecular medicine, 2021, Volume: 47, Issue:5

Topics: Acute Lung Injury; Animals; Cytokines; Lipoxins; Male; Malondialdehyde; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Paraquat; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Pulmonary Edema; Rats, Sprague-Dawley; RAW 264.7 Cells; Superoxide Dismutase; Toll-Like Receptor 4

2021